RBC Bioscience (ROCO:6848) Total Liabilities : NT$523.6 Mil (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is RBC Bioscience Total Liabilities?

RBC Bioscience's Total Liabilities for the quarter that ended in Jun. 2024 was NT$523.6 Mil.

RBC Bioscience's quarterly Total Liabilities declined from Jun. 2023 (NT$526.61 Mil) to Dec. 2023 (NT$513.08 Mil) but then increased from Dec. 2023 (NT$513.08 Mil) to Jun. 2024 (NT$523.57 Mil).

RBC Bioscience's annual Total Liabilities declined from Dec. 2021 (NT$590.77 Mil) to Dec. 2022 (NT$541.73 Mil) and declined from Dec. 2022 (NT$541.73 Mil) to Dec. 2023 (NT$513.08 Mil).

RBC Bioscience Total Liabilities Historical Data

The historical data trend for RBC Bioscience's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RBC Bioscience Total Liabilities Chart

RBC Bioscience Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

113.22

337.89

590.77

541.73

513.08

RBC Bioscience Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Total Liabilities	Get a 7-Day Free Trial						563.40	541.73	526.61	513.08	523.57

RBC Bioscience Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

RBC Bioscience's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	99.765	+	(412.598	+	0.71800000000002
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	513.1

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	753.79	-	240.709
	=	513.1

RBC Bioscience's Total Liabilities for the quarter that ended in Jun. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	123.44	+	(399.381	+	0.74900000000008
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	523.6

Total Liabilities	=	Total Assets (Q: Jun. 2024 )	-	Total Equity (Q: Jun. 2024 )
	=	771.714	-	248.144
	=	523.6

RBC Bioscience Total Liabilities Related Terms

Thank you for viewing the detailed overview of RBC Bioscience's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

RBC Bioscience Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RBC Bioscience Corp (ROCO:6848) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lane 235, Baoqiao Road, 3rd Floor, No. 132, New Taipei City, TWN, 23145

Website

https://www.rbcbioscience.com

RBC Bioscience Corp is a bio sciences company. Its products include Real Genomics, MagCore Automated Nucleic Acid Extractor, and MagCore Nucleic Acid Extraction KIT.

RBC Bioscience Headlines

No Headlines